342
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Potentially inappropriate concomitant medicine use with the selective COX-2 inhibitor celecoxib: Analysis and comparison of spontaneous adverse event reports from Australia, Canada and the USA.

, , , , &
Pages 153-161 | Received 01 Oct 2018, Accepted 22 Feb 2019, Published online: 30 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Oxana Tsigengagel, Makpal Alchimbayeva, Zaituna Khismetova & Natalya Glushkova. (2023) The public’s views on responsibility for medical errors in Kazakhstan. International Journal of Healthcare Management 16:3, pages 362-368.
Read now

Articles from other publishers (4)

Xianwen Chen, Lisong Yang, Xueli Liu, He Zhu, Fei Yu, Carolina Oi Lam Ung, Hao Hu, Waisin Chan, Honghao Shi & Sheng Han. (2021) Drug Utilization for Pain Management during Perioperative Period of Total Knee Arthroplasty in China: A Retrospective Research Using Real-World Data. Medicina 57:5, pages 451.
Crossref
Paulo A. Moraes, Evelyne S. Brum, Indiara Brusco, Mário A. Marangoni, Marcio M. Lobo, Adriano F. Camargo, Pablo A. Nogara, Helio G. Bonacorso, Marcos A. P. Martins, João Batista T. Da Rocha, Sara M. Oliveira & Nilo Zanatta. (2020) Pyrazole‐Enaminones as Promising Prototypes for the Development of Analgesic Drugs. ChemistrySelect 5:46, pages 14620-14625.
Crossref
Huanzhi Ma, Wei Zhang, Jun Shi, Dongsheng Zhou & Jian Wang. (2020) The efficacy and safety of extracorporeal shockwave therapy in knee osteoarthritis: A systematic review and meta-analysis. International Journal of Surgery 75, pages 24-34.
Crossref
Bin Wen, Ying-Ting Wei, Lan-Lan Mu, Guo-Rong Wen & Kui Zhao. (2020) The molecular mechanisms of celecoxib in tumor development. Medicine 99:40, pages e22544.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.